Chembio Diagnostics Inc. is collaborating with FIND to develop a point-of-care test that can identify multiple life-threatening acute febrile illnesses common in the Asia-Pacific region.

During the next 12 months, the collaboration aims to develop a simple, rapid, and cost-effective test based on Chembio's Dual Path Platform technology platform to detect multiple diseases simultaneously.

Chembio's test will be designed to include a quality control and nine tests aimed at parasitic, viral and bacterial pathogens commonly responsible for fever symptoms in the Asia-Pacific region, including malaria, dengue virus, zika virus, chikungunya virus, leptospirosis, rickettsia typhi, burkholderia pseudomallei and orientia tsutsugamushi.

FIND is a global nonprofit dedicated to accelerating the development, evaluation and delivery of high-quality, affordable diagnostic tests for poverty-related diseases, including tuberculosis, malaria, HIV/AIDS, Ebola, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease and Buruli ulcer, as well as for fighting antimicrobial resistance and supporting outbreak preparedness.